Navigation Links
Great Point Partners Completes Growth Equity Investment in Axiom Real-Time Metrics
Date:5/8/2019

Great Point Partners (“GPP”) today announced a growth recapitalization of Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services that are used to enhance the efficiency of Phase I, II and III clinical trials and observational studies. Axiom is a leading e-clinical technology company that focuses on Electronic Data Capture (“EDC”), Data Management (“DM”), Clinical Trial Management Systems (“CTMS”), Randomization (“IWRS”), Electronic Patient Reported Outcomes (“ePRO”) and other technology and service solutions for biotechnology and pharmaceutical sponsors conducting clinical trials. Founded in 2001 and based in Toronto, Canada, the Company will leverage this funding to scale its technology system and superior customer service.

“From the beginning of our conversation when they proactively approached us about a partnership, Great Point demonstrated its expertise in the clinical trial service needs of biotechnology and pharmaceutical companies, Axiom’s core customer base. Their market knowledge and the depth of their experience investing in pharmaceutical services companies made them an ideal partner for Axiom as we enter our next phase of growth. GPP’s investment will allow Axiom to increase the level of customer service and add additional technology solutions and services,” said Andrew Schachter, Founder and CEO of Axiom.

“We are excited to partner with the Axiom team and help them execute an accelerated growth plan,” said Noah Rhodes, Managing Director at Great Point Partners. “Andrew and his team have built an impressive business that has been growing at 56% per year over the last six years. We look forward to introducing Andrew to the biotechnology CEOs in our network, all of whom are either current or potential customers for Axiom’s products and services.”

“Our work in the trenches alongside drug developers over the last decade has proven that there is a huge need for Axiom’s solutions. This need is reflected in their explosive growth and superb customer satisfaction reported to us by the CEOs who are their customers,” said Eddie Hjerpe, Senior Associate at Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, Conn., is a leading health care investment firm with approximately $1.6 billion of equity capital currently under management and 28 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP III, which has committed capital of $280 million. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III, $280 million in committed capital) and public equity funds (BMVF, approximately $1.1 billion). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at 203-971-3300 or http://www.gppfunds.com.

About Axiom Real-Time Metrics

Headquartered in Toronto, Canada, Axiom delivers intuitive, powerful and cost-effective eClinical solutions and services focused around your entire study. Services include: Data Management, Data Analytics, Biostatistics and Pharmacovigilance. Axiom's eClinical suite, Fusion, delivers a powerful range of innovative end-user focused, unified functionality and more than 15 modules. Axiom serves as the Connected Hub for your entire clinical study data and operational needs. Fusion Delivers: EDC, DM, IWRS, CTMS, Inventory Management, IVR, Patient Portal, AE/SAE Tracking, Safety Database, Central Lab, Imaging, eTMF, and 24/7 Project and Clinical Data Reporting. For more information, please visit http://www.axiommetrics.com/.

Read the full story at https://www.prweb.com/releases/great_point_partners_completes_growth_equity_investment_in_axiom_real_time_metrics/prweb16297121.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. VetStem Biopharma is Pleased to Share the Success Story of Jack, a Great Pyrenees who was Treated with Stem Cell Therapy by Dr. Andrea Hayes
2. NXT-IDs Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing"
3. Plant communities produce greater yield than monocultures
4. Study identifies gauntlet of obstacles facing migrating pronghorn in greater Yellowstone
5. Americans rate losing eyesight as having greatest impact on their lives
6. Expedition finds Nemo can travel great distances to connect populations
7. Small algae with great potential
8. Natura 2000 could do a great deal more for nature protection
9. Exposure to toxins makes great granddaughters more susceptible to stress
10. Fires above the Great Slave Lake in Canada
11. Despite a significant reduction in smog-producing toxins, the Greater Toronto Area still violates Canadas standards for ozone air pollution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2019)... , ... May 24, 2019 , ... Zolgensma (Novartis, AveXis), ... AVXS-101, was approved for clinical use in the United States by the Food and ... gene therapy approved to treat inherited genetic disorders in the United States and the ...
(Date:5/23/2019)... ... May 23, 2019 , ... Federal Publications Seminars, the leading provider of government ... the release of FPSOnline 2.0, an updated version of its FPSOnline platform. ... La Jolla Government Contracts Week, were given a “sneak peek” of FPSOnline 2.0 during ...
(Date:5/23/2019)... ... May 23, 2019 , ... ... sales and service organizations, today announced its inclusion in DMG Consulting’s 2019-2020 Intelligent ... intelligent virtual agent (IVA) market share leader, based on number of customers, with ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... (PRWEB) , ... June 10, 2019 , ... ... of its distribution network with the appointment of Biofeedback Tech Ltd ... monitoring systems are an essential part of many therapeutic treatments and clinical assessment ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today ... (MSC-EV) are able to incorporate into human CD34+ cells, modifying their gene expression ... also increased the cells’ ability to lodge into bone marrow. This research performed ...
(Date:5/31/2019)... BEACH, Calif. (PRWEB) , ... May 30, 2019 ... ... future of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., ... research. The acquisition provides Object exclusive ownership and commercialization rights to a full ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are the magic bullet ... products rely on these ingredients to create stable quality food that can withstand ... shift triggers food formulators to seek out alternatives for starches, gums and chemical ...
Breaking Biology Technology: